Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions

Journal of Parenteral and Enteral Nutrition

Volumn 36, Issue 5, 2012, Pages 587-595

  Angsten, Gertrud ^a   Finkel, Yigael ^b   Lucas, Steven ^a   Kassa, Ann Marie ^a   Paulsson, Mattias ^c   Lilja, Helene Engstrand ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

6 9 lipid emulsion; fish oil based lipid emulsion; intestinal failure associated liver disease (IFALD); short bowel syndrome

Indexed keywords

BILIRUBIN; CLINOLEIC; INTRALIPID; OMEGAVEN;

ARTICLE; CHOLESTASIS; CLINICAL ARTICLE; DRUG DOSE INCREASE; FEMALE; GESTATIONAL AGE; HUMAN; LIVER FAILURE; MALE; MORTALITY; NEWBORN; PARENTERAL NUTRITION; PREMATURITY; PRIORITY JOURNAL; PROPENSITY SCORE; RETROSPECTIVE STUDY; SHORT BOWEL SYNDROME; SURVIVAL RATE; TREATMENT DURATION; TREATMENT OUTCOME;

BILIRUBIN; CHOLESTASIS; EMULSIONS; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, OMEGA-6; FEMALE; FISH OILS; HUMANS; INFANT; INTESTINAL DISEASES; INTESTINES; LIVER FAILURE; LIVER FUNCTION TESTS; LOGISTIC MODELS; MALE; PARENTERAL NUTRITION; PARENTERAL NUTRITION SOLUTIONS; RETROSPECTIVE STUDIES; SHORT BOWEL SYNDROME; SOYBEAN OIL; TREATMENT OUTCOME;

EID: 84865211753     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607111430507     Document Type: Article

References (48)

1. Wales PW, de Silva N, Kim JH, Lecce L, Sandhu A, Moore AM. Neonatal short bowel syndrome: a cohort study. J Pediatr Surg. 2005 ; 40: 755-762 (Pubitemid 40724842)
2. Andorsky DJ, Lund DP, Lillehei CW, et al. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr. 2001 ; 139: 27-33 (Pubitemid 32613983)
3. de Meijer VE, Gura KM, Le HD, Meisel JA, Puder M. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. JPEN J Parenter Enteral Nutr. 2009 ; 33: 541-547
4. Christensen RD, Henry E, Wiedmeier SE, Burnett J, Lambert DK. Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease. J Perinatol. 2007 ; 27: 284-290 (Pubitemid 46647905)
5. Grant D, Abu-Elmagd K, Reyes J, et al. 2003 report of the intestine transplant registry: a new era has dawned. Ann Surg. 2005 ; 241: 607-613 (Pubitemid 40397308)
6. Fecteau A, Atkinson P, Grant D. Early referral is essential for successful pediatric small bowel transplantation: the Canadian experience. J Pediatr Surg. 2001 ; 36: 681-684 (Pubitemid 32417261)
7. Beath SV, Davies P, Papadopoulou A, et al. Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors. J Pediatr Surg. 1996 ; 31: 604-606 (Pubitemid 26115658)
8. Kelly DA. Liver complications of pediatric parenteral nutrition: epidemiology. Nutrition. 1998 ; 14: 153-157 (Pubitemid 28049003)
9. Teitelbaum DH, Tracy T. Parenteral nutrition-associated cholestasis. Semin Pediatr Surg. 2001 ; 10: 72-80 (Pubitemid 32422655)
10. Van Aerde JE, Duerksen DR, Gramlich L, et al. Intravenous fish oil emulsion attenuates total parenteral nutrition-induced cholestasis in newborn piglets. Pediatr Res. 1999 ; 45: 202-208 (Pubitemid 29075996)
11. Beckh K, Kneip S, Arnold R. Direct regulation of bile secretion by prostaglandins in perfused rat liver. Hepatology. 1994 ; 19: 1208-1213 (Pubitemid 24134243)
12. Yeh SL, Chang KY, Huang PC, Chen W. Effects of n-3 and n-6 fatty acids on plasma eicosanoids and liver antioxidant enzymes in rats receiving total parenteral nutrition. Nutrition. 1997 ; 13: 32-36 (Pubitemid 27098611)
13. Chen WJ, Yeh SL. Effects of fish oil in parenteral nutrition. Nutrition. 2003 ; 19: 275-279
14. Alwayn IP, Gura K, Nosé V, et al. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res. 2005 ; 57: 445-452 (Pubitemid 40293615)
15. Gura KM, Duggan CP, Collier SB, et al. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics. 2006 ; 118: 197-201
16. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics. 2008 ; 121: 678-686
17. Diamond IR, Sterescu A, Pencharz PB, Kim JH, Wales PW. Changing the paradigm: Omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr. 2009 ; 48: 209-215
18. Ekema G, Falchetti D, Boroni G, et al. Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (omega-3 fatty acids). J Pediatr Surg. 2008 ; 43: 1191-1195 (Pubitemid 351814874)
19. Sigalet D, Boctor D, Robertson M, et al. Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease. Eur J Pediatr Surg. 2009 ; 19: 348-353
20. De Meijer VE, Le HD, Meisel JA, Gura KM, Puder M. Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients. J Pediatr Gastroenterol Nutr. 2010 ; 50: 212-218
21. Lilja HE, Finkel Y, Paulsson M, Lucas S. Prevention and reversal of intestinal failure-associated liver disease in premature infants with short bowel syndrome using intravenous fish oil in combination with omega-6/9 lipid emulsions. J Pediatr Surg. 2011 ; 46: 1361-1367
22. Wilmore DW. Factors correlating with a successful outcome following extensive intestinal resection in newborn infants. J Pediatr. 1972 ; 80: 88-95
23. Touloukian RJ, Smith GJ. Normal intestinal length in preterm infants. J Pediatr Surg. 1983 ; 18: 720-723 (Pubitemid 14175261)
24. Quirós-Tejeira RE, Ament ME, Reyen L, et al. Long-term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: a 25-year experience. J Pediatr. 2004 ; 145: 157-163 (Pubitemid 38993385)
25. Nasr A, Avitzur Y, Ng VL, De Silva N, Wales PW. The use of conjugated hyperbilirubinemia greater than 100 micromol/L as an indicator of irreversible liver disease in infants with short bowel syndrome. J Pediatr Surg. 2007 ; 42: 359-362 (Pubitemid 46161559)
26. Cowles RA, Ventura KA, Martinez M, et al. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation. J Pediatr Surg. 2010 ; 45: 84-88
27. Dudrick SJ, Wilmore DW, Vars HM, Rhoads JE. Long-term total parenteral nutrition with growth, development, and positive nitrogen balance. Surgery. 1968 ; 64: 134-142
28. Wilmore DW, Dudrick SJ. Growth and development of an infant receiving all nutrients exclusively by vein. JAMA. 1968 ; 203: 860-864
29. Zambrano E, El-Hennawy M, Ehrenkranz RA, Zelterman D, Reyes-Múgica M. Total parenteral nutrition induced liver pathology: an autopsy series of 24 newborn cases. Pediatr Dev Pathol. 2004 ; 7: 425-432 (Pubitemid 40385233)
30. Gambarara M, Ferretti F, Papadatou B, et al. Intestinal adaptation in short bowel syndrome. Transplant Proc. 1997 ; 29: 1862-1863 (Pubitemid 27203704)
31. Colomb V, Jobert-Giraud A, Lacaille F, Goulet O, Fournet JC, Ricour C. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr. 2000 ; 24: 345-350
32. Javid PJ, Collier S, Richardson D, et al. The role of enteral nutrition in the reversal of parenteral nutrition-associated liver dysfunction in infants. J Pediatr Surg. 2005 ; 40: 1015-1018 (Pubitemid 40840821)
33. Clayton PT, Whitfield P, Iyer K. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition. 1998 ; 14: 158-164 (Pubitemid 28049004)
34. Carter BA, Taylor OA, Prendergast DR, et al. Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr Res. 2007 ; 62: 301-306 (Pubitemid 47301479)
35. Carter BA, Shulman RJ. Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis. Nat Clin Pract Gastroenterol Hepatol. 2007 ; 4: 277-287 (Pubitemid 46711465)
36. Wanten GJ, Calder PC. Immune modulation by parenteral lipid emulsions. Am J Clin Nutr. 2007 ; 85: 1171-1184 (Pubitemid 46740457)
37. Wanten GJ, Janssen FP, Naber AH. Saturated triglycerides and fatty acids activate neutrophils depending on carbon chain-length. Eur J Clin Invest. 2002 ; 32: 285-289 (Pubitemid 36216595)
38. Calder PC. Dietary modification of inflammation with lipids. Proc Nutr Soc. 2002 ; 61: 345-358 (Pubitemid 34982924)
39. Schmöcker C, Weylandt KH, Kahlke L, et al. Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines. Hepatology. 2007 ; 45: 864-869 (Pubitemid 46631554)
40. El-Badry AM, Moritz W, Contaldo C, et al. Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids. Hepatology. 2007 ; 45: 855-863 (Pubitemid 46631553)
41. Calder PC. Use of fish oil in parenteral nutrition: rationale and reality. Proc Nutr Soc. 2006 ; 65: 264-277 (Pubitemid 46323841)
42. Zaman N, Tam YK, Jewell LD, et al. Effects of intravenous lipid as a source of energy in parenteral nutrition associated hepatic dysfunction and lidocaine elimination: a study using isolated rat liver perfusion. Biopharm Drug Dispos. 1997 ; 18: 803-819 (Pubitemid 27517569)
43. Goulet O, Joly F, Corriol O, Colomb-Jung V. Some new insights in intestinal failure-associated liver disease. Curr Opin Organ Transplant. 2009 ; 14: 256-261
44. Day CP, James OF. Steatohepatitis: a tale of two "hits"?. Gastroenterology. 1998 ; 114: 842-845
45. Deshpande GC, Simmer K, Mori T, Croft K. Parenteral lipid emulsions based on olive oil compared with soybean oil in preterm (<28 weeks' gestation) neonates: a randomised controlled trial. J Pediatr Gastroenterol Nutr. 2009 ; 49: 619-625
46. Lauritzen L, Hansen HS, Jørgensen MH, Michaelsen KF. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res. 2001 ; 40: 1-94 (Pubitemid 32008650)
47. Rivera JC, Sapieha P, Joyal JS, et al. Understanding retinopathy of prematurity: update on pathogenesis. Neonatology. 2011 ; 100: 343-353
48. Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated injury. Ann Surg. 2009 ; 250: 395-402